Companies / Resmed Inc

Resmed Inc

NYSE: RMDCIK 943819Health CareSAN DIEGO, CAresmed.com ↗

Financials · FY2026

Revenue$5.65B
Net income$1.52B
Total debt$659.37M
Cash$1.47B
Diluted EPS$10.43
Shares outstanding145.1M

Ownership

145.1M shares outstanding · as of Apr 27, 2026
0.43%Insiders
Ownership
Insiders0.43%620,182
10%+ / strategic5.71%8,276,381
Institutions68.15%98,854,779
Public float25.72%37,305,042

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Farrell Michael J.CEOChairman and CEO · Director
0.32%466,223
Sandercock BrettChief Financial Officer
0.06%83,495
Farrell Peter CDirector
0.04%60,773
Rider Michael JGlobal General Counsel
<0.01%9,691

Institutional holders 959

View all →
HolderValue% of shares
Vanguard Group Inc$4.55B13.02%
BlackRock, Inc.$2.40B8.49%
State Street Corporation$1.30B4.61%
Bank of New York Mellon Corp/The$1.11B3.40%
Geode Capital Management, LLC$973.79M3.00%
Morgan Stanley$696.52M1.99%
Invesco Ltd.$470.16M1.35%
Northern Trust Corp$430.05M1.23%
First Trust Advisors LP$345.21M1.06%
Charles Schwab Investment Management Inc$265.79M0.76%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 9, 2026Farrell Michael J.
CEO
SellResMed Common Stock$1.37M-5K
-1.06%
466,223
0.32% of shares
medium
Mar 9, 2026Farrell Michael J.
CEO
SellResMed Common Stock$1.25M-5K
-1.06%
466,223
0.32% of shares
medium
Jan 7, 2026Farrell Michael J.
CEO
SellResMed Common Stock$1.24M-5K
-1.06%
466,223
0.32% of shares
medium
Mar 9, 2026Farrell Michael J.
CEO
ExerciseResMed Common Stock$730.4K+5K
+1.07%
471,214
0.32% of shares
low
Feb 9, 2026Farrell Michael J.
CEO
ExerciseResMed Common Stock$730.4K+5K
+1.07%
471,214
0.32% of shares
low
Jan 7, 2026Farrell Michael J.
CEO
ExerciseResMed Common Stock$730.4K+5K
+1.07%
471,214
0.32% of shares
low
Mar 4, 2026Farrell Peter C
Director
SellResMed Common Stock$520.4K-2K
-3.09%
62,773
0.04% of shares
medium
Feb 4, 2026Farrell Peter C
Director
SellResMed Common Stock$502.6K-2K
-3.00%
64,773
0.04% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
AustralianSuper Pty LtdPassive13G—8,276,381—
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RMD——761152107—